SCHEMBL23329154

SCHEMBL23329154

O=C(NC1CCCCC1)c1cc(-n2cccn2)cc2cc[nH]c12

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CD38 P28907 7/20 0.54
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
CNR2 P34972 5/20 0.43
CNR1 P21554 4/20 0.43
ALDH1A1 P00352 3/20 0.43
GAA P10253 3/20 0.43
HTT P42858 1/20 0.43
APOBEC3G Q9HC16 1/20 0.43
KAT7 O95251 1/20 0.41
RAB9A P51151 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
KMT2A Q03164 2/20 0.40
MEN1 O00255 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP3A4 P08684 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
KDM4E B2RXH2 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23329160 0.84 CD38 (0.76) CD38
SCHEMBL23329521 0.84 CD38 (0.71) CD38NPC1MAPTALDH1A1GAA
SCHEMBL20612949 0.82 CD38 (0.78) CD38
SCHEMBL20612910 0.76 NPC1 (0.51) CD38NPC1MAPTCNR2ALDH1A1
SCHEMBL20612933 0.76 NPC1 (0.52) CD38NPC1MAPTCNR2ALDH1A1
SCHEMBL31036797 0.74 CD38 (0.71) CD38
SCHEMBL31036795 0.73 CD38 (0.73) CD38
SCHEMBL23329507 0.71 CD38 (0.72) CD38NPC1MAPTCNR2CNR1
SCHEMBL31036791 0.70 CD38 (1.00) CD38
SCHEMBL22936248 0.69 CD38 (0.71) CD38

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021087087-A1 N-CYCLOHEXYL-5-(THIAZOL-5-YL)-1H-INDOLE-7-CARBOXAMIDE DERIVATIVES AND RELATED COMPOUNDS AS CD38 INHIBITORS FOR INCREASING NAD+ AND FOR THE TREATMENT OF E.G. MUSCULAR DISORDERS MITOBRIDGE INC. (US) 2021-05-06 WO disclosed